Spatiotemporal analyses illuminate the competitive advantage of a SARS-CoV-2 variant of concern over a variant of interest
View ORCID ProfileAlexis Russell, Collin O’Connor, View ORCID ProfileErica Lasek-Nesselquist, Jonathan Plitnick, John P. Kelly, View ORCID ProfileDaryl M. Lamson, View ORCID ProfileKirsten St. George
doi: https://doi.org/10.1101/2021.09.14.21262977
Alexis Russell
1Laboratory of Viral Diseases, Wadsworth Center, New York State Department of Health, Albany, NY 12208, USA
Collin O’Connor
2Division of Epidemiology, New York State Department of Health, Albany, NY 12242, USA
3Department of Geography, University at Buffalo, Buffalo, NY 14260
Erica Lasek-Nesselquist
4Bioinformatics Core, Wadsworth Center, New York State Department of Health, Albany, NY 12208, USA
5Department of Biomedical Science, University at Albany, SUNY, Albany, NY 12208, USA
Jonathan Plitnick
1Laboratory of Viral Diseases, Wadsworth Center, New York State Department of Health, Albany, NY 12208, USA
John P. Kelly
6Applied Genomic Technology Core, Wadsworth Center, New York State Department of Health, Albany, NY 12208, USA
Daryl M. Lamson
1Laboratory of Viral Diseases, Wadsworth Center, New York State Department of Health, Albany, NY 12208, USA
Kirsten St. George
1Laboratory of Viral Diseases, Wadsworth Center, New York State Department of Health, Albany, NY 12208, USA
5Department of Biomedical Science, University at Albany, SUNY, Albany, NY 12208, USA
Data Availability
The sequence data that support the findings of this study are openly available in GISAID.org. The disease incidence and location data are not publicly available due to their containing information that could compromise the privacy of patients.
Posted September 20, 2021.
Spatiotemporal analyses illuminate the competitive advantage of a SARS-CoV-2 variant of concern over a variant of interest
Alexis Russell, Collin O’Connor, Erica Lasek-Nesselquist, Jonathan Plitnick, John P. Kelly, Daryl M. Lamson, Kirsten St. George
medRxiv 2021.09.14.21262977; doi: https://doi.org/10.1101/2021.09.14.21262977
Spatiotemporal analyses illuminate the competitive advantage of a SARS-CoV-2 variant of concern over a variant of interest
Alexis Russell, Collin O’Connor, Erica Lasek-Nesselquist, Jonathan Plitnick, John P. Kelly, Daryl M. Lamson, Kirsten St. George
medRxiv 2021.09.14.21262977; doi: https://doi.org/10.1101/2021.09.14.21262977
Subject Area
Subject Areas
- Addiction Medicine (362)
- Allergy and Immunology (682)
- Anesthesia (183)
- Cardiovascular Medicine (2722)
- Dermatology (234)
- Emergency Medicine (411)
- Epidemiology (12369)
- Forensic Medicine (10)
- Gastroenterology (782)
- Genetic and Genomic Medicine (4223)
- Geriatric Medicine (394)
- Health Economics (697)
- Health Informatics (2725)
- Health Policy (1013)
- Hematology (369)
- HIV/AIDS (873)
- Medical Education (404)
- Medical Ethics (111)
- Nephrology (450)
- Neurology (4001)
- Nursing (216)
- Nutrition (592)
- Oncology (2110)
- Ophthalmology (602)
- Orthopedics (250)
- Otolaryngology (309)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (475)
- Pediatrics (1143)
- Primary Care Research (465)
- Public and Global Health (6626)
- Radiology and Imaging (1439)
- Respiratory Medicine (882)
- Rheumatology (418)
- Sports Medicine (350)
- Surgery (460)
- Toxicology (57)
- Transplantation (192)
- Urology (171)